227 related articles for article (PubMed ID: 34246971)
1. Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study.
Azimi F; Azizian H; Najafi M; Hassanzadeh F; Sadeghi-Aliabadi H; Ghasemi JB; Ali Faramarzi M; Mojtabavi S; Larijani B; Saghaei L; Mahdavi M
Bioorg Chem; 2021 Sep; 114():105127. PubMed ID: 34246971
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
3. Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase.
Wei M; Chai WM; Wang R; Yang Q; Deng Z; Peng Y
Bioorg Med Chem; 2017 Feb; 25(4):1303-1308. PubMed ID: 28110817
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B
Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
6. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.
Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI
Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast α-glucosidase.
Kashtoh H; Muhammad MT; Khan JJ; Rasheed S; Khan A; Perveen S; Javaid K; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Bioorg Chem; 2016 Apr; 65():61-72. PubMed ID: 26874344
[TBL] [Abstract][Full Text] [Related]
8. In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives.
Chaudhry F; Naureen S; Huma R; Shaukat A; Al-Rashida M; Asif N; Ashraf M; Munawar MA; Khan MA
Bioorg Chem; 2017 Apr; 71():102-109. PubMed ID: 28160945
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor.
Azimi F; Azizian H; Najafi M; Khodarahmi G; Saghaei L; Hassanzadeh M; Ghasemi JB; Faramarzi MA; Larijani B; Hassanzadeh F; Mahdavi M
Sci Rep; 2021 Oct; 11(1):20776. PubMed ID: 34675367
[TBL] [Abstract][Full Text] [Related]
13. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
[TBL] [Abstract][Full Text] [Related]
19. Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.
Sherafati M; Mirzazadeh R; Barzegari E; Mohammadi-Khanaposhtani M; Azizian H; Sadegh Asgari M; Hosseini S; Zabihi E; Mojtabavi S; Ali Faramarzi M; Mahdavi M; Larijani B; Rastegar H; Hamedifar H; Hamed Hajimiri M
Bioorg Chem; 2021 Apr; 109():104703. PubMed ID: 33609917
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
